We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Statements from SACN and the Committee on Toxicity (COT) on the health benefits and risks of using potassium-based sodium replacers in the UK.
Check the tariff classification for peptide nisin standardised with sodium chloride
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved (27 December 2024) the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH).
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Check the tariff classification for analytical methods for determining the fat, starch and protein content within Chapters 11 and 23.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
As with any medicine, the MHRA will keep the safety of gepotidacin under close review.
Guidance on sodium and potassium cyanide for use in responding to chemical incidents.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).